Studi Antiviral Andrographis Paniculata, For Herpes Simplex Virustipe 1 (HSV-1) Treatment: In Slico Study | Zendy

Resmi Mustarichie | Zendy; Sandra Megantara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Studi Antiviral Andrographis Paniculata, For Herpes Simplex Virustipe 1 (HSV-1) Treatment: In Slico Study

Author(s) -

Resmi Mustarichie,

Sandra Megantara

Publication year - 2021

Publication title -

asian journal of pharmaceutical research and development

Language(s) - English

Resource type - Journals

ISSN - 2320-4850

DOI - 10.22270/ajprd.v9i6.1036

Subject(s) - andrographis paniculata , herpes simplex virus , hsl and hsv , medicine , virology , traditional medicine , pharmacology , virus , alternative medicine , pathology

Herpes simplex virus type 1 (HSV-1) is a lifelong infectious disease. Research and drug development for this disease continues to be developed. Andrographis paniculata or commonly known as Sambiloto is a plant that is commonly used empirically as an HSV-1 drug. Further research is needed to determine the effectiveness of these plants as candidates for HSV-1 treatment. This study will determine several bioactive compounds contained in Sambiloto against the HSV-1 receptor in an insilico study which can be the basis for the discovery of new drugs in the treatment of HSV-1 infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research